Somatostatin is present in high concentrations in human seminal plasma. Semen was obtained from men with spinal cord injury by vibratory-and/or electrostimulation. The seminal somatostatin concentration and sperm motility rate depended on the location of the spinal cord lesion. In men with lesions at or above T6 the seminal plasma concentration was significantly decreased compared to healthy men and to patients with lesions below T6 (P < 0.005). The latter group did not differ from healthy men. Men with spinal cord lesions below T6 had significantly decreased sperm motility rates (P = 0.09) compared to patients with lesions at or above T6. Seminal somatostatin concentrations were similar in vibratory-and electrostimulated ejaculates. The seminal somatostatin concentration, semen volume, sperm count, motility and morphology in each patient was not affected when repeated vibratory ejaculations were performed at home.
Introduction
Men with spinal cord injury (SCI) suffer in general from ejaculatory dysfunction. 1 By penile vibratory stimulation or rectal electrostimulation it is possible to retrieve sperm from the vast majority of SCI men.1,2 However, the semen quality in SCI men is often poor.2,3 In particular, low motility and viability of spermatozoa obtained by electrostimulation have been noted and only a minority of SCI men have normal cervical mucus penetration tests. 3 The reasons for these deficiencies are uncertain. Hirsh et al4 demonstrated a low mean spermatid and high Sertoli cell count per seminiferous tubule in testis biopsies from SCI men. Neurogenic factors may play a role, as indicated by the fact that the most severe effects on maturation of the germinal cells are seen when the spinal cord lesion includes TlO-L2.5
Human seminal plasma contains high concentrations of somatostatin, the concentrations being approxi mately 200 times higher than in blood plasma./; The molecular form has been identified as somatostatin-64,6 in contrast to somatostatin-14 found in many tissues and somatostatin-28 most prominent in the intestine.7 Somatostatin, acting as a hormone or a neurotrans mitter, behaves as an inhibitor of cell functions including hormone secretion, muscle contraction and cell growth.8 As the concentration of somatostatin-64 in seminal plasma from vasectomised men is signifi cantly higher than in normal men, the synthesis of somatostatin-64 possibly takes place in the male acces sory sex glands. 6 The aim of the present study was to determine the seminal concentration of somatostatin and investigate if it could be correlated with semen quality (sperm count, volume, motility and morphology) in SCI men.
Materials and methods

Patients
Twelve SCI men were included in this study (Table 1) with a median age of 30 years (range 21-45 years). Median interval from SCI to study entry was 7 years (range 1-29 years). The level of spinal cord lesions was determined as the most caudal, normal functioning spinal cord segment. In complete lesions no sacral sparing was present. The neurological level of the cord lesion ranged from C2 to T12. Nine lesions were complete and three incomplete. None of the patients was able to obtain antegrade ejaculation during normal sexual stimulation. The study protocol was approved by the regional ethical committee, and patients were included only when oral and written informed consent was obtained.
Semen retrieval
All patients underwent penile vibratory stimulation to induce ejaculation as described by SjI)nksen et ai, 1 with a vibrator calibrated to a peak-to-peak amplitude of 2.5 mm and a frequency of 100 Hz. Rectal electrostimu lation9 was performed if no antegrade ejaculation was obtained by penile vibratory stimulation. However, two patients (patients 7 and 10, see Table 1 ) obtaining antegrade ejaculation by vibratory stimulation had also had electrostimulation resulting in ante grade ejacula tion.
Five patients underwent a home programme of repeated vibratory stimulation to induce ejaculation once weekly for a period between 6 and 12 months. Antegrade ejaculates were obtained for semen and somatostatin analysis every 3 months in the outpatient clinic.
Semen analysis
Semen analyses of the ante grade ejaculates were carried out within 40 min of ejaculation. The volume, sperm count, motility and morphology were deter mined according to WHO laboratory standards. 1 0
Seminal plasma extraction
Semen was frozen at -20°C within 30 min. Upon thawing proteinase inhibitors were added to the follow ing final concentrations: benzamidine 50 mM, EDTA 0.3 mM, leupeptin 1,uM, pepstatin 0.5 liM and PMSF 100 JlM. The sperm was centrifuged at 2000 G for 20 min at 4°C and seminal plasma was isolated. The extr . action of the seminal plasma was performed by adding one volume to four volumes of boiling water and boiling for 45 min. 6 Immunoassay Somatostatin was measured using antiserum R37 (kindly provided by Dr Jens F Rehfeld, Department of Clinical Biochemistry, Rigshospitalet, the National University Hospital, Copenhagen, Denmark) directed against the sequences -Cys-Lys-Asn-Phe-Phe-in somatostatin-14 produced in rabbits as previously described.ll Tracer, incubation condition and separa tion were in accordance with the previous description by 0dum et al.12 Detection limit of the assay is 0.1 nmol l-1.
Statistical analysis
The Mann-Whitney two-sample rank sum test was used.
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Results
Patient data are shown in Table 1 . In addition seminal plasma somatostatin concentrations and sperm motility rates are shown. No difference between the concen trations of somatostatin in the vibrated (median = 0 nmol l-1, range: 0-13.8, n = 7) and electrostimulated patients (median = 2.8 nmol l-1, range: 0-5.6, n = 7) was detected (P = 0.62). As seen from Table 1, semen from patients with spinal cord lesions at T6 or above contained no somatostatin in the first sample obtained. The somatostatin concentration in this group was significant�y lower (P < 0.005) than that of healthy � en (medIan = 3.1 nmol l-1, range: 0.6-76)6 and signi fIcantly lower (P < 0.005) than in patients with spinal cord lesions below T6 (median = 4.3 nmol l-1, range: 0.5-13.8, first sample of each patient). In contrast, patients with spinal cord lesions below T6 had normal seminal plasma somatostatin concentrations.
The somatostatin concentration was not significantly affected by repeated vibration stimulated ejaculations performed at home, as indicated by rather constant concentrations at outpatient visits at 3 month intervals ( Figure 1) . Furthermore, no effects on the semen volume, sperm count, motility and morphology were seen by repeated vibration stimulated ejaculations.
Seminal plasma somatostatin concentration did not correlate with semen volume, sperm count, or morpho logy. Sperm motility rates in patients with spinal cord lesions below T6 (median = 0% motile, range: 0-30) was marginally significantly (P = 0.09) lower than in patients with spinal cord lesions at or above T6 (median = 16% motile, range: 10-37).
There was a trend toward lower motility in samples containing somatostatin compared to samples with out somatostatin (correlation coefficient = -0.66) ( Table 1) .
Discussion
Poor semen quality in SCI men has been attributed to several factors such as abnormal testicular histology, recurrent urinary tract infections, stasis of prostatic fluids and changes in the hypothalamic-pituitary axis. 13 We found normal FSH, LH and testosterone levels in the patient group (not shown). Low sperm motility rates are well-known in SCI men.2,3.13 We observed this phenomenon in all patients when compared to WHO standardslO and, in particular, in the group of SCI men with lesions of low thoracolumbar spinal cord segments in accordance with histological changes of the testes in such patients.5 Somatostatin-64 does not originate from testis or epididymis, but possibly from male accessory sex glands.6 These glands are known to be innervated from sympathetic nerve fibres from the thoracolumbar spinal cord (T11-L2) and marginally from parasympathetic fibres from the sacral spinal cord (S2_S4).3,14 Surpris ingly, all patients with spinal cord lesions at or above T6 had no somatostatin in the seminal plasma. This might suggest that the secretion of somatostatin into the semen is dependent on nerve fibres arising above this level.
Seminal somatostatin did not correlate with semen volume, sperm count, or morphology. Motility was better in samples without than in samples with somato statin although all samples were below WHO standards for sperm motility.lO Preliminary data suggest that somatostatin is not an inhibitor of sperm motility (unpublished data). Therefore, the negative correlation between seminal somatostatin and sperm motility may be a consequence of the SCI level rather than an effect of somatostatin on the motility. Apparently, the spinal cord level of T6 may be an important dividing line when consequences of the influence of SCI on semen quality are studied.
